Skip to main navigation Skip to search Skip to main content

Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: A case report for a cancer of unknown primary origin

  • Pedro Torres-Ayuso
  • , Sudhakar Sahoo
  • , Garry Ashton
  • , Elvira An
  • , Nicole Simms
  • , Melanie Galvin
  • , Hui Sun Leong
  • , Kristopher K. Frese
  • , Kathryn Simpson
  • , Natalie Cook
  • , Andrew Hughes
  • , Crispin J. Miller
  • , Richard Marais
  • , Caroline Dive
  • , Matthew G. Krebs
  • , John Brognard
  • University of Manchester
  • National Institutes of Health
  • The Christie NHS Foundation Trust

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: A case report for a cancer of unknown primary origin'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry